amit@unlistedkraft.in
+91-9599071664
+91-9599071664
Martin and Harris Laboratories Limited Unlisted Shares
DRHP Status : Not Filed
845
Fundamentals About Martin and Harris Laboratories Limited
Downloads & Investor Documents
All documents are provided for informational purposes and are subject to regulatory disclosures.
Key Financials of Martin and Harris Laboratories Limited
About Company
The following table shows a 10-point analysis of Martin and Harris Laboratories Limited. We will discuss each point in detail after this table.
| Parameter | Key Numbers | Insights |
|---|---|---|
| Business Overview | Incorporated 1993 | A pharmaceutical manufacturing and investment-focused company. |
| Industry | Pharmaceuticals | Operates in drugs, formulations, and investment activities. |
| Group Affiliation | Part of Apeejay Group | Strong legacy backing and diversified business exposure. |
| Core Business Mix | Pharma + Investments | Revenue split between pharma manufacturing and investment income. |
| Manufacturing Units | Uttarakhand · Himachal Pradesh | Facilities for complex dosage forms and formulations. |
| Revenue | ₹146 Cr (FY24) | Decline compared to FY23 due to lower operational income. |
| Profitability | ₹40 Cr PAT (FY24) | Strong profitability despite revenue decline. |
| Net Worth | ₹632 Cr (FY24) | Strong balance sheet with large reserves. |
| Debt Position | Near debt-free | Very low leverage ensures financial stability. |
| Outlook | Stable with investment income | Supported by strong treasury and pharma operations. |
Company Overview
(i) Martin and Harris Laboratories Limited is a pharmaceutical company engaged in manufacturing drugs, medicinal products, and specialty formulations, along with investment activities.
(ii) The company is part of the Apeejay Group, a well-established business conglomerate with diversified interests, providing strong institutional backing.
(iii) Its business model is unique, with a combination of pharmaceutical manufacturing and investment income, which contributes significantly to overall profitability.
(iv) The company operates manufacturing facilities in Uttarakhand and Himachal Pradesh, equipped to produce complex dosage forms and specialty products.
(v) It also actively manages investments across mutual funds, listed and unlisted securities, creating an additional income stream alongside its core pharma operations.
Challenges in Martin and Harris Laboratories Limited’s Business
- Revenue volatility due to dual business model: Dependence on both pharma and investment income can lead to fluctuations in earnings.
- Declining core pharma revenue: Recent financials show a drop in operational revenue, impacting overall growth trajectory.
- Regulatory risks in the pharma sector: Strict compliance requirements and approvals may impact operations and costs.
- Capital allocation risks: Investment portfolio performance directly impacts profitability.
Financial Review of Martin and Harris Laboratories Limited
Here are some highlights of the financial performance of Martin and Harris Laboratories Limited over the past few years.
FY24 Performance
• Revenue from operations stood at ₹146 crore
• EBITDA reported at ₹60 crore
• Profit before tax stood at ₹55 crore
• Profit after tax reported at ₹40 crore
FY23 Performance
• Revenue from operations stood at ₹205 crore
• EBITDA reported at ₹96 crore
• Profit before tax stood at ₹92 crore
• Profit after tax reported at ₹68 crore
FY22 Performance
• Revenue from operations stood at ₹186 crore
• EBITDA reported at ₹70 crore
• Profit before tax stood at ₹93 crore
• Profit after tax reported at ₹70 crore
Quick Summary
Martin and Harris Laboratories Limited is a unique pharma plus investment-driven company with strong profitability and a robust balance sheet. While recent revenue has declined, the company continues to maintain healthy margins supported by investment income and low debt levels.
Click Here to visit the official website of Martin and Harris Laboratories Limited.
Promoters of Martin and Harris Laboratories Limited
The following are the active promoters/leadership associated with the company:
| Name | Designation | LinkedIn Profile |
|---|---|---|
| Sushma Paul Berlia | Promoter | - |
| Apeejay Group | Promoter Group | - |
Shareholding Pattern of Martin and Harris Laboratories Limited
Latest News
Latest Post
Coming soon...
Coming soon...
Frequently Asked Questions
Martin and Harris Laboratories Limited unlisted shares are equity shares of the company that are not listed on NSE or BSE and are traded privately.
Yes, Martin and Harris Laboratories Limited unlisted shares can be purchased through private market platforms, subject to availability.
Yes, a demat account is required to hold Martin and Harris Laboratories Limited unlisted shares.
The company has a strong balance sheet and profitability, but like all unlisted investments, it carries liquidity and business risks.
Yes, Martin and Harris Laboratories Limited unlisted shares can be sold in the secondary market depending on demand and availability.
Yes, as per SEBI regulations, pre-IPO investors are subject to a six-month lock-in period after listing.
If held for more than two years, gains are taxed at 20% with indexation; otherwise, taxed as per the income slab.
+91-9599071664
amit@unlistedkraft.in